CNBX Pharmaceuticals Inc CNBX
$0.00 $0.00 (25.00%) 1D
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
CNBX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, CNBX Pharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
CNBX Pharmaceuticals Inc. Stock Analysis CNBX
United States Health Care Nano Cap CNBX Pharmaceuticals, Inc. is a clinical stage company, which engages in the discovery, development, and commercialization of cannabinoid-based products and technologies for the treatment of cancer. The company is headquartered in Bethesda, Maryland and currently employs 1 full-time employees. The company went IPO on 2007-07-02. The Company’s first lead product candidate is Cannabics SR, the oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS). Its anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) is RCC-33, a therapy being developed primarily in two settings: one to reduce tumor cell activity in CRC patients as a standalone in neoadjuvant treatment or window of opportunity at the time after colonoscopy, prior to cancer staging, and another for patients with refractory to therapy and adjuvant to surgery also at the time after colonoscopy. The firm intends to initiate Phase I/II clinical trials for both candidates: Cannabics SR and RCC-33.
CNBX Pharmaceuticals Inc (CNBX) Chart
Financial Metrics & Statements of CNBX Pharmaceuticals Inc (CNBX)
FAQ's for CNBX Pharmaceuticals Inc (CNBX)
- As of August 2026, CNBX Pharmaceuticals Inc CNBX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CNBX Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in CNBX Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of CNBX Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of CNBX Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of CNBX Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for CNBX Pharmaceuticals Inc (CNBX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
